Showing results (21-30 of 62) with videos related to
Sort By:
Pageof 7
Journal of Hepatology|March 4, 2008
Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy studyMaribel Rodríguez-Torres, Sugantha Govindarajan, Ricard Solá, et al.AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.Scientific Reports|December 7, 2016
Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease InhibitorsAmit Kumar, Wasim Abbas, Sophie Bouchat, et al.AIDS (London, England)|November 7, 2006
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infectionEduardo Lissen, Nathan Clumeck, Ricardo Sola, et al.AIDS (London, England)|July 17, 2014
First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited settingNathan Clumeck, Claude Mwamba, Kabamba Kabeya, et al.The Journal of Infectious Diseases|August 10, 2006
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA studyDaria Podlekareva, Amanda Mocroft, Ulrik B Dragsted, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2007
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfectionMilos Opravil, Joe Sasadeusz, David A Cooper, et al.Cancer|June 16, 2004
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA StudyAmanda Mocroft, Ole Kirk, Nathan Clumeck, et al.AIDS (London, England)|December 17, 2009
The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/mlJose R Arribas, Andrzej Horban, Jan Gerstoft, et al.Cancer|July 28, 2010
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignanciesJoanne Reekie, Csaba Kosa, Frederik Engsig, et al.Pageof 7